Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M46.5Revenue $M0.2Net Margin (%)-10,865.6Altman Z-Score-6.6
Enterprise Value $M30.6EPS $-0.1Operating Margin %-12,044.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-10,865.6Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %--Quick Ratio4.6Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-0.9Current Ratio4.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-53.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-61.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M233ROIC % (ttm)-198.8Gross Margin Increase y-yN

Gurus Latest Trades with HEB

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

HEB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


HEB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CARTER WILLIAM ACEO, 10% Owner 2015-04-28Buy100,000$0.24-16.67 view
Equels Thomas K.CFO, Vice Chairman, Secretary 2015-04-27Buy100,000$0.24-16.67 view
CARTER WILLIAM ACEO, 10% Owner 2015-04-21Buy100,000$0.24-16.67 view
Equels Thomas K.CFO, Vice Chairman, Secretary 2015-04-20Buy100,000$0.24-16.67 view
CARTER WILLIAM ACEO, 10% Owner 2015-04-17Buy73,681$0.23-13.04 view
CARTER WILLIAM ACEO, 10% Owner 2015-04-16Buy26,319$0.23-13.04 view
Equels Thomas K.CFO, Vice Chairman, Secretary 2015-04-15Buy100,000$0.23-13.04 view
STRAYER DAVID RMedical Director 2012-05-18Buy50,000$0.26-23.08 view
Lander Russel JVP of Process/QualityAssurance 2011-03-01Buy50,000$0.46-56.52 view
Lander Russel JVP of Process/QualityAssurance 2010-08-23Buy4,910$0.51-60.78 view

Quarterly/Annual Reports about HEB:

News about HEB:

Articles On GuruFocus.com
Siva Jun 27 2015 
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-K/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q) Nov 08 2010 
Weekly CEO Sells Highlight: Hemispherx Biopharma Inc, ADESA Inc, Entergy Corp, and Danaher Corp. Aug 15 2010 
Hemispherx Biopharma Inc Reports Operating Results (10-Q) Aug 06 2010 
Hemispherx Biopharma Inc (HEB) CEO William A Carter buys 500,000 Shares Jul 01 2010 
Weekly CFO Buys Highlight: Wireless Telecom Group, ValueVision Media, American River Bankshares, Hem Dec 12 2009 

More From Other Websites
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Hemispherx... Jun 30 2015
Hemispherx Receives the European Patent Office Examining Division’s Notice of Intention to Grant... Jun 25 2015
Hemispherx Receives the European Patent Office Examining Division's Notice of Intention to Grant the... Jun 25 2015
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jun 24 2015
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Hemispherx... Jun 11 2015
Hemispherx Biopharma Announces Preliminary Approval of Securities Class Action Settlement Jun 04 2015
Hemispherx Biopharma Announces Preliminary Approval of Securities Class Action Settlement Jun 04 2015
Phila. biotech firm agrees to pay $2.75M settlement Jun 03 2015
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Hemispherx... Jun 02 2015
Hemispherx Biopharma Europe N.V./S.A. : Orphan Medicine Designation and European Medicines Agency... May 26 2015
Hemispherx Biopharma Europe N.V./S.A.: Orphan Medicine Designation and European Medicines Agency... May 26 2015
HEMISPHERX BIOPHARMA INC Financials May 22 2015
Hemispherx to Present at the Marcum Microcap Conference in New York ….Planned Launch of Alferon N... May 20 2015
Hemispherx to Present at the Marcum Microcap Conference in New York May 20 2015
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Hemispherx... May 18 2015
10-Q for Hemispherx Biopharma, Inc. May 14 2015
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2015 May 13 2015
HEMISPHERX BIOPHARMA INC Files SEC form 10-Q, Quarterly Report May 12 2015
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation by the European Medicines... May 11 2015
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation by the European Medicines... May 11 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK